New clue in the hunt for treatments that slow ageing
New research published today has identified a vital new target in the search for treatments that can slow ageing, and could one day prevent Parkinson's.
New drug for hallucinations and delusions moves a step closer
In March the advisory panel for the US Food and Drug Administration approved a new drug for treating hallucinations and delusions in Parkinson's
First trial of stem cells for Parkinson's announced
California-based company, the International Stem Cell Corporation (ISCO), has announced the first clinical trials of a stem cell treatment for Parkinson's.
Research reveals impact of thinking difficulties on communication in Parkinson's
New research suggests that thinking difficulties may be more to blame than physical symptoms for speech problems in Parkinson's.
Common dementia drug could improve Parkinson's symptoms
Researchers at the University of Bristol have discovered that a common dementia drug, rivastigmine, could reduce falls in people with Parkinson's.
Picturing Parkinson's - a scientific art form
Today we announce the top images in our 2015 Picturing Parkinson's competition, celebrating the beauty and art in the research we fund.
Dr Patrick Lewis: The promise of genetic research for Parkinson's
Parkinson's UK research fellow Dr Patrick Lewis writes about the ultimate goal of carrying out research into Parkinson's to develop new drugs that will make a difference to millions.
New research 'one step closer' to diagnosing early Parkinson's
Research we've funded has brought us closer to diagnosing early stage Parkinson's – thanks to a new MRI scanning technique.
Our research offers vital new insights into Parkinson's
We have some important new results to share from our largest ever project - The Monument Discovery Award at the University of Oxford.